# Rewire

> Context for emerging medicine research


## Posts

- [Cancer Vaccines Are Moving Beyond Prevention](https://oxpeptide.com/cancer-vaccines-moving-beyond-prevention/): Personalized mRNA cancer vaccines are designed around features of an individual tumor. Early trial results are worth watching, but they are not proof that the approach works on its own or for every cancer.
- [Alzheimer’s Drugs Can Slow Decline, Not Reverse It](https://oxpeptide.com/alzheimers-drugs-slow-decline-not-reverse-it/): Lecanemab changed the conversation about Alzheimer’s treatment by targeting amyloid in the brain. Its trial results point to slower decline for some people—not restored memory or a cure.
- [CRISPR for Sickle Cell: What Changes](https://oxpeptide.com/crispr-for-sickle-cell-what-changes/): The first CRISPR-based treatment approved in the United States offers a new route for some people with sickle cell disease. The edit is precise; the treatment around it is demanding.

## Pages

- [Contact](https://oxpeptide.com/contact/)
- [About](https://oxpeptide.com/about/)
- [Research](https://oxpeptide.com/blog/)
- [Home](https://oxpeptide.com/)


[comment]: # (Generated by Hostinger Tools Plugin)